At just over three and a half years old, the medical cannabis market in Germany is still quite young - compared to other disciplines in the pharmaceutical sector. Nevertheless, new legal adjustments, an increasing number of market participants trying to get the small amount of imported goods, bad news about delivery bottlenecks, the constant battle for acceptance of cannabis as a medicinal plant and, last but not least, the global corona pandemic are causing turbulent ups and downs in the industry: This article shows INSIGHTS from current developments in the medical cannabis market.

Read more